Stem Cell Company Persuades Employers To Steer Workers Toward Controversial Therapy
Regenexx, which runs a string of clinics, says stem cell injections can save employers a lot of money, but critics say there’s no proof.
Elite Hospitals Plunge Into Unproven Stem Cell Treatments
Critics are concerned about the explosion in controversial stem cell procedures offered by clinics — and, increasingly, respected hospitals.
Prestigiosos hospitales se lanzan al negocio de terapias con células madre no aprobadas
Los tratamientos típicos consisten en inyectar las articulaciones de los pacientes con sus propias células grasas o de médula ósea, o con extractos de plaquetas. No está comprobado científicamente que funcionen.
Health Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
Hasta un tercio de los reemplazos de rodilla causan dolor… y arrepentimiento
Los 723,000 reemplazos de rodilla realizados en 2014 costaron a pacientes, aseguradoras y contribuyentes más de $40.000 millones. No siempre funcionan.
Up To A Third Of Knee Replacements Pack Pain And Regret
Many patients face lingering pain and disappointment after undergoing knee replacement surgery, which costs an average $31,000. And doctors are increasingly concerned that the procedure is overused and that its benefits have been oversold.
Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
Píldoras de aceite de pescado y de vitamina D no protegen contra el cáncer o males cardíacos
Los investigadores definieron los males cardíacos graves como el índice combinado de ataques cardíacos, apoplejía y muertes relacionadas con el corazón.
Soda Industry Steals Page From Tobacco To Combat Taxes On Sugary Drinks
Voters in Oregon, Washington will decide whether to strip cities of ability to tax sugary drinks.
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.